Which emphasizing factors are most predictive of hematoma expansion in spot sign positive intracerebral hemorrhage? 2014

So Hyun Kim, and Hyun Ho Jung, and Kum Whang, and Jong Yun Kim, and Jin Su Pyen, and Ji Woong Oh
Department of Neurosurgery, Wonju Severance Christian Hospital, Yonsei University, Wonju, Korea.

OBJECTIVE The spot sign is related with the risk of hematoma expansion in spontaneous intracerebral hemorrhage (ICH). However, not all spot sign positive patients undergo hematoma expansion. Thus, the present study investigates the specific factors enhancing the spot sign positivity in predicting hematoma expansion. METHODS We retrospectively studied 316 consecutive patients who presented between March 2009 to March 2011 with primary ICH and whose initial computed tomography brain angiography (CTA) was performed at our Emergency Department. Of these patients, 47 primary ICH patients presented spot signs in their CTA. We classified these 47 patients into two groups based on the presence of hematoma expansion then analyzed them with the following factors : gender, age, initial systolic blood pressure, history of anti-platelet therapy, volume and location of hematoma, time interval from symptom onset to initial CTA, spot sign number, axial dimension, and Hounsfield Unit (HU) of spot signs. RESULTS Of the 47 spot sign positive patients, hematoma expansion occurred in 26 patients (55.3%) while the remaining 21 (44.7%) showed no expansion. The time intervals from symptom onset to initial CTA were 2.42±1.24 hours and 3.69±2.57 hours for expansion and no expansion, respectively (p=0.031). The HU of spot signs were 192.12±45.97 and 151.10±25.14 for expansion and no expansion, respectively (p=0.001). CONCLUSIONS The conditions of shorter time from symptom onset to initial CTA and higher HU of spot signs are the emphasizing factors for predicting hematoma expansion in spot sign positive patients.

UI MeSH Term Description Entries

Related Publications

So Hyun Kim, and Hyun Ho Jung, and Kum Whang, and Jong Yun Kim, and Jin Su Pyen, and Ji Woong Oh
January 2017, BioMed research international,
So Hyun Kim, and Hyun Ho Jung, and Kum Whang, and Jong Yun Kim, and Jin Su Pyen, and Ji Woong Oh
September 2018, World neurosurgery,
So Hyun Kim, and Hyun Ho Jung, and Kum Whang, and Jong Yun Kim, and Jin Su Pyen, and Ji Woong Oh
April 2007, Stroke,
So Hyun Kim, and Hyun Ho Jung, and Kum Whang, and Jong Yun Kim, and Jin Su Pyen, and Ji Woong Oh
September 2021, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,
So Hyun Kim, and Hyun Ho Jung, and Kum Whang, and Jong Yun Kim, and Jin Su Pyen, and Ji Woong Oh
November 2017, Clinical neurology and neurosurgery,
So Hyun Kim, and Hyun Ho Jung, and Kum Whang, and Jong Yun Kim, and Jin Su Pyen, and Ji Woong Oh
August 2016, Neurocritical care,
So Hyun Kim, and Hyun Ho Jung, and Kum Whang, and Jong Yun Kim, and Jin Su Pyen, and Ji Woong Oh
September 2017, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,
So Hyun Kim, and Hyun Ho Jung, and Kum Whang, and Jong Yun Kim, and Jin Su Pyen, and Ji Woong Oh
December 2012, Neurocritical care,
So Hyun Kim, and Hyun Ho Jung, and Kum Whang, and Jong Yun Kim, and Jin Su Pyen, and Ji Woong Oh
April 2011, Neurology,
So Hyun Kim, and Hyun Ho Jung, and Kum Whang, and Jong Yun Kim, and Jin Su Pyen, and Ji Woong Oh
August 2010, Neurology,
Copied contents to your clipboard!